ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

[1]  B. Cheson,et al.  Novel therapies for chronic lymphocytic leukemia. , 2004, Blood reviews.

[2]  Adrian Wiestner,et al.  ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. , 2003, Blood.

[3]  Emili Montserrat,et al.  ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. , 2003, The New England journal of medicine.

[4]  Tetsuya Nakamura,et al.  Unexpected requirement for ZAP-70 in pre-B cell development and allelic exclusion. , 2003, Immunity.

[5]  D. Oscier,et al.  Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. , 2003, Blood.

[6]  Arthur Weiss,et al.  Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. , 2002, Blood.

[7]  Xiao-Jie Yan,et al.  Chronic Lymphocytic Leukemia B Cells Can Undergo Somatic Hypermutation and Intraclonal Immunoglobulin VHDJH Gene Diversification , 2002, The Journal of experimental medicine.

[8]  A. Pettitt,et al.  Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia. , 2002, Blood.

[9]  Axel Benner,et al.  Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. , 2002, Blood.

[10]  D. Oscier,et al.  Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. , 2002, Blood.

[11]  Göran Roos,et al.  Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. , 2002, Blood.

[12]  R. Bataille,et al.  CD38 expression and secondary 17p deletion are important 
prognostic factors in chronic lymphocytic leukaemia , 2002, British journal of haematology.

[13]  E. Solary,et al.  CD 38 expression may vary during the course of the disease independent prognostic variables in chronic lymphocytic leukemia , but CD 38 expression and immunoglobulin variable region mutations are , 2002 .

[14]  David Botstein,et al.  Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia , 2001, The Journal of experimental medicine.

[15]  Y. Tu,et al.  Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells , 2001, The Journal of experimental medicine.

[16]  S. Toyabe,et al.  Specific immunoglobulin E responses in ZAP‐70‐deficient patients are mediated by Syk‐dependent T‐cell receptor signalling , 2001, Immunology.

[17]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[18]  T J Hamblin,et al.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.

[19]  N. Chiorazzi,et al.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.

[20]  E. Kimby,et al.  Chemotherapeutic Options in Chronic Lymphocytic Leukemia: a Meta-analysis of the Randomized Trials , 1999 .

[21]  Ash A. Alizadeh,et al.  The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. , 1999, Cold Spring Harbor symposia on quantitative biology.

[22]  T. Kipps.  Chronic lymphocytic leukemia , 1998, Current opinion in hematology.

[23]  M. Grever,et al.  National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.

[24]  T. Kurosaki,et al.  Reconstitution of Syk function by the ZAP-70 protein tyrosine kinase. , 1995, Immunity.

[25]  I. Tomlinson,et al.  The human immunoglobulin VH repertoire. , 1995, Immunology today.

[26]  A. Weiss,et al.  Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. , 1994, Journal of immunology.

[27]  Arthur Weiss,et al.  ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR ζ chain , 1992, Cell.

[28]  A. Givan,et al.  THE RELEVANCE OF A MORE SENSITIVE CROSSMATCH ASSAY TO RENAL TRANSPLANTATION , 1989, Transplantation.